The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.
Device: NIO® (Intraosseous access)
obtaining intravascular access using a ready intravenous NIO needle set
Other Name: IO
Device: Standard of Care (Intravenous access)
obtaining intravascular access using a standard intravenous cannula
Other Name: IV
Inclusion Criteria:
- Out-of-hospital cardiac arrest (OHCA)
- Adult ≥ 18 years old
- Non-traumatic cause of cardiac arrest
Exclusion Criteria:
- Existing do-not-attempt-resuscitation order
- OHCA patients with contraindications to IO access or IV access
- Patients with signs of obvious death, e.g. rigor mortis
Lazarsku University
Warsaw, Masovian, Poland
Lukasz Szarpak, PhD, Study Chair
Lazarski University